Washington, D.C. (May 5, 2014) – The Biotechnology Industry Organization (BIO) is pleased to announce the winners of the 2014 BIO International Convention® Buzz of BIO contest, recognizing highly innovative companies in the biotech sector. The Convention attracts the biggest names in biotech, regularly draws 15,000 attendees, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry.
More than 40 companies participated in this year’s competition and over 8,000 votes were tallied in all. Due to this record-breaking number of votes, two winners will be recognized from each of the two categories: Pipelines of Promise and Technologies of Tomorrow.
Winners: Technologies of Tomorrow
BNOAT Oncology, Inc. (Akron, Ohio)
HNu-nanoPOINT (Kahului, Hawaii)
Winners: Pipelines of Promise
Kibow Biotech Inc. (Newtown Square, Pennsylvania)
Novan Therapeutics (Durham, North Carolina)
Winners will receive one complimentary Convention Access and Partnering registration to the BIO International Convention™, which includes access to the BIO Business Forum™, the BIO One-on-One Partnering™ system, as well as a 15-minute company presentation spot.
“The Buzz of BIO competition spotlights emerging companies that are R&D intensive and helps position them to develop strategic partnerships within the industry,” said BIO International Convention President Scott Whitaker. “We are very pleased to have such dynamic companies as our Buzz of BIO winners this year and hope the contest created a platform for them to meet potential new investors and partner companies at our upcoming Convention.”
More on the winners:
Kibow Biotech was founded in 1997 is a dietary supplement company, specializing in drug like validation of patented, proprietary probiotic product towards help in maintaining a healthy kidney function. Kibow is best known for its animal (Azodyl®) and human (Renadyl™) supplements for help in kidney failure problems.
Novan Therapeutics is a clinical-stage specialty pharmaceutical company bringing the power of nitric oxide to dermatology and wound care. Novan is currently developing a range of nitric oxide-releasing drug products including topical gels, creams, ointments, and wound dressings which can be rationally tailored to treat specific skin conditions.
BNOAT Oncology is an oncology research and development company headquartered in Ohio on the Akron Innovation Campus of the University of Akron. BNOAT has the only license to develop cobalamin-based, non-toxic, anti-tumor agents for the imaging and treatment of both human and animal cancers.
HNu-nanoPOINT is a leading developer of compact microfluidic systems. HNu-nanoPOINT’s instrument is a multipurpose in vivo platform for stem cell research where cell maintenance and reagent delivery is automated and cells imaged with varying time-course options and viewed remotely at the researchers’ convenience.
Advance media registration is available for qualified reporters working full time for print, broadcast and web publications with valid press credentials. To register, please visit here.
About the BIO Business Forum
The BIO Business Forum has grown over the past thirteen years to become the industry's largest partnering event, hosting a record breaking 25,500+ partnering meetings in 2013. Powered by BIO's One-on-One Partnering™ System, the BIO Business Forum™ fosters the opportunity for companies to initiate business contacts in a friendly environment and schedule private meetings prior to the Convention.
World Congress on Industrial Biotechnology
May 12-15, 2014
BIO International Convention
June 23-26, 2014
San Diego, CA
BIO Latin America Conference
September 9-11, 2014
Rio de Janeiro, Brazil
Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD